HCPCS Code Descriptor:
Injection, sotrovimab, 500 mg
Route of Administration:
Potential NDC Listing Errors:
Our team has identified potential listing errors/discrepancies with the following NDCs:
Please contact us regarding potential compendia errors/discrepancies
Sotrovimab Injection is a COVID-19 drug manufactured by GSK and administered via the Intravenous route of administration. The Q Code: Q0247 is aligned to the drug Sotrovimab Injection.